Hormone und Intensivpatienten

Schlüsselwörter

intensivierte Glukosekontrolle - Intensivpatienten - LowT3-Syndrom - Vasopressin - Glukokortikoide

Keywords

tight glucose control - critical care - low t3 syndrome - vasopressin - glucocorticoids

• Literatur

• 1 Annane D, Maxime V, Ibrahim F et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174: 1319-1326
• 2 Cheng CJ, Lin SH, Lo YF et al. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem 2011; 286: 27425-27435 Erratum in 286: 33707
• 3 Finfer S et al . NiceSugarInvestigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367: 1108-1118
• 4 Lanspa MJ, Hirshberg EL, Phillips GD et al. Moderate glucose control is associated with increased mortality compared to tight glucose control in critically ill non-diabetics. Chest 2012; Nov 29.doi: DOI: 10.1378/chest.12-2072. [Epub ahead of print]
• 5 Lin SH, Chu P, Cheng CJ et al. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio. Crit Care Med 2006; 34: 2984-2989
• 6 Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Int Med 2012; 23: 564-574
• 7 Marik PE, Pastores SM, Annane D et al. American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949
• 8 Mebis L, vdBerghe G. Thyroid axis function and dysfunction in critical illness. Best pract res clin endocrinol metab 2011; 25: 745-757
• 9 NICE-SUGAR Study Investigators . Finfer S, Chittock DR et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
• 10 Polito A, Parinsi E, Ricci Z et al. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med 2012; 38: 9-19
• 11 Russel JA, Walley KR, Singer J et al. Vasopressin versus norepinephrin infusion in patients with septic shock. N Engl J Med 2008; 358: 877-887
• 12 Russel JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care 2011; 15: 226-245
• 13 Ryan DP, da Silva MR, Soong TW et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2010; 140: 88-98
• 14 Serpa Neto A, Nassar AP, Cardoso SO et al. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care 2012; 16: 154-163
• 15 Sprung CL, Annane D, Keh D et al. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-124
• 16 Tas A, Köklü S, Beyazit Y et al. Thyroid hormone levels predict mortality in intensive care patients with cirrhosis. Am J Med Sci 2012; 344: 175-179
• 17 Todd SR, Sim V, Moore LJ et al. The identification of thyroid dysfunction in surgical sepsis. J Trauma Acute Care Surg 2012; 73: 1457-1460
• 18 van den Heuvel I, Ellger B. Endokrinologische Störungen bei Intensivpatienten. Anästh Intensivmed 2011; 52: 82-96